Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
234 Leser
Artikel bewerten:
(0)

Insignia Health Launches SMART on FHIR Application to Directly Administer the Patient Activation Measure (PAM) Survey Within Epic

PORTLAND, Oregon, Aug. 25, 2020 /PRNewswire/ -- Insignia Health, a leading provider of health activation solutions and services, recently announced availability of the Patient Activation Measure (PAM) SMART App through Epic's App Orchard.

Patient Activation Measure (PAM) SMART App Logo

PAM is a 10- or 13 item survey that assesses a person's underlying knowledge, skills and confidence integral to managing his or her own health and healthcare. The assessment segments individuals into one of four increasing levels of activation along a 100-point scale. Each level, backed by over a decade of research, provides insight into an extensive array of health-related characteristics, including attitudes, motivators, and behaviors.

PAM is a predictive powerhouse used by health systems, hospitals, health plans, government programs and life science firms in the United States and abroad to improve health outcomes, reduce costs and deliver higher quality healthcare.

Now available through the Epic App Orchard, the PAM survey can be directly administered to patients by front-line healthcare professionals through their native Epic electronic health record platform and scored instantly. Results may also be tracked over time from within the PAM App.

"Our new SMART on FHIR app allows for seamless integration, saving time for care teams and capturing patients' PAM results within established workflows," said Chris Delaney, Chief Executive Officer, Insignia Health. "We are thrilled to be able to streamline the use of PAM for our clients using Epic."

Clinical and non-clinical staff will be able to easily access PAM activation levels to guide support and develop patient-centered care plans. Re-administration of the PAM survey and assessing score changes can measure the effectiveness of interventions, allowing for patient support to be adjusted accordingly. PAM score and activation level history can be easily tracked over time within the patient record.

For more information on using the PAM survey on Epic and to begin using the application, visit the Epic App Orchard marketplace.

About Insignia Health
Insignia Health is a global provider of PAM-based health activation solutions that help organizations rigorously measure a person's self-management ability and then align resources and tailor support accordingly. The Patient Activation Measure (PAM) is a predictive powerhouse backed by over 15 years of health activation research and insight gained from supporting hospitals, health systems, insurers, life science companies and government health agencies around the globe. The company's products and services have proven through extensive published research to increase activation resulting in declines in preventable utilization, lower costs and improved health outcomes. Insignia Health is headquartered in Portland, Oregon. Visit InsigniaHealth.com to learn more.

Jim Honish
jhonish@insigniahealth.com

Insignia Health Logo

Logo - https://mma.prnewswire.com/media/1243394/PAM_Flourish_logo_Logo.jpg
Logo - https://mma.prnewswire.com/media/1243395/Insignia_Health_Logo_Logo.jpg

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2020 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.